HCV NS3-4A protease inhibitors (Abbott)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHCV NS3-4A protease inhibitors (Abbott)
Drug Alias NameP-3 aza-peptidomimetic analogs (Abbott)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 inhibitors
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A